G-CSF Stimulation and Coronary Reinfusion of Mobilized Circulating Mononuclear Proangiogenic Cells in Patients with Chronic Ischemic Heart Disease: Five-Year Results of the TOPCARE-G-CSF Trial

G-CSF Stimulation and Coronary Reinfusion of Mobilized Circulating Mononuclear Proangiogenic Cells in Patients with Chronic Ischemic Heart Disease: Five-Year Results of the TOPCARE-G-CSF Trial

Prognosis of patients with heart failure remains poor despite improved conventional and interventional treatment regimens. The improvement of neovascularization and repair processes by administration of bone marrow-derived cells modestly improved the recovery after acute myocardial infarction. Howev...

Full description

Bibliographic Details
Main Authors: Joerg Honold, Ulrich Fischer-Rasokat, Ralf Lehmann, David M. Leistner, Florian H. Seeger, Volker Schachinger, Hans Martin, Stefanie Dimmeler, Andreas M. Zeiher, Birgit Assmus M.D.
Format: Article
Language:English
Published: SAGE Publishing 2012-11-01
Series:Cell Transplantation
Online Access:https://doi.org/10.3727/096368912X654957

Internet

https://doi.org/10.3727/096368912X654957

Similar Items